Arcus Biosciences, Inc.RCUSNYSE
LOADING
|||
Cash Flow Under Pressure
Trending higher, below historical average, strong compound growth.
Left:
||||
Operating cash flow minus capital expenditures
Latest
$-176.00M
↓ 279% below average
Average (8y)
$-46.43M
Historical baseline
Range
High:$432.00M
Low:$-330.00M
CAGR
+33.9%
Consistent expansion
| Period | Value | Change |
|---|---|---|
| 2024 | $-176.00M | +46.7% |
| 2023 | $-330.00M | -176.4% |
| 2022 | $432.00M | +253.1% |
| 2021 | $-282.25M | -361.1% |
| 2020 | $108.11M | +243.4% |
| 2019 | $-75.39M | -61.3% |
| 2018 | $-46.74M | -52.9% |
| 2017 | $-30.57M | -79.4% |
| 2016 | $-17.04M | - |